Published in Circulation on February 14, 2012
Increased risk of venous thromboembolism is associated with genetic variation in heme oxygenase-1 in Blacks. Thromb Res (2012) 0.81
Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost (2016) 0.78
Replication of a genetic risk score for venous thromboembolism in whites but not in African Americans. J Thromb Haemost (2015) 0.77
Bilateral Pulmonary Embolism after a Short-Haul Flight in a Man with Multiple Risk Factors including Sickle Cell Trait. Case Rep Emerg Med (2017) 0.75
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood (2003) 3.04
Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol (2007) 2.70
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol (2010) 2.26
Sickle cell trait and the risk of venous thromboembolism among blacks. Blood (2007) 1.95
Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood (2004) 1.82
Hypercoagulability in sickle cell disease: new approaches to an old problem. Hematology Am Soc Hematol Educ Program (2007) 1.65
D-dimer antigen: current concepts and future prospects. Blood (2008) 1.59
Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol (2004) 1.58
Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Blood (2014) 1.53
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI. Blood (2012) 1.48
Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A (2007) 1.48
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res (2009) 1.43
Major burn injury is not associated with acute traumatic coagulopathy. J Trauma Acute Care Surg (2013) 1.43
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients. Blood (2011) 1.43
Blood coagulation: hemostasis and thrombin regulation. Anesth Analg (2009) 1.24
High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol (2010) 1.23
Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood (2012) 1.20
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment. Am J Hematol (2009) 1.18
Association of coagulation activation with clinical complications in sickle cell disease. PLoS One (2012) 1.17
Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology (2013) 1.11
Plasma protein profiling: unique and stable features of individuals. Proteomics (2005) 1.11
Hemostatic abnormalities in sickle cell disease. Curr Opin Hematol (2013) 1.08
Effects of tissue factor, thrombomodulin and elevated clotting factor levels on thrombin generation in the calibrated automated thrombogram. Thromb Haemost (2009) 1.07
Microparticles in cardiovascular disease pathophysiology and outcomes. J Am Soc Hypertens (2012) 1.01
Centrifugation is a crucial step impacting microparticle measurement. Platelets (2009) 0.98
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers. Thromb Res (2013) 0.97
Hepatitis C in adults and adolescents with hemophilia: a randomized, controlled trial of interferon alfa-2b and ribavirin. Hepatology (2002) 0.97
Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol (2009) 0.96
Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis. Br J Haematol (2012) 0.95
NF-kappaB transcription factor p50 critically regulates tissue factor in deep vein thrombosis. J Biol Chem (2008) 0.95
Measurement of bleeding severity: a critical review. Transfusion (2004) 0.93
Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood (2012) 0.93
Novel oral anticoagulants: implications in the perioperative setting. Anesthesiology (2010) 0.93
Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood (2013) 0.93
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients. Thromb Haemost (2007) 0.91
Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity. Thromb Res (2011) 0.91
Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection. Analyst (2003) 0.90
Microparticles and cancer. Pathophysiol Haemost Thromb (2009) 0.89
Platelet factor 4 enhances generation of activated protein C in vitro and in vivo. Blood (2003) 0.89
Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica (2007) 0.89
Acquired hemophilia in malignancy. Thromb Res (2012) 0.88
A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease. Thromb Res (2013) 0.88
Circulating levels of tissue factor microparticle procoagulant activity are reduced with antiretroviral therapy and are associated with persistent inflammation and coagulation activation among HIV-positive patients. J Acquir Immune Defic Syndr (2013) 0.87
Postoperative coagulopathy in a pediatric patient after exposure to bovine topical thrombin. Ann Thorac Surg (2007) 0.87
Hematologic changes in sepsis and their therapeutic implications. Semin Respir Crit Care Med (2004) 0.86
Elevated whole-blood tissue factor procoagulant activity as a marker of restenosis after percutaneous transluminal coronary angioplasty and stent implantation. Circulation (2003) 0.86
Association of soluble fms-like tyrosine kinase-1 with pulmonary hypertension and haemolysis in sickle cell disease. Br J Haematol (2011) 0.85
Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol (2003) 0.84
Venous thromboembolism in multiple myeloma: current perspectives in pathogenesis. Eur J Cancer (2010) 0.84
Activated recombinant factor VII in cardiac surgery. Curr Opin Anaesthesiol (2005) 0.84
Mice with heterozygous deficiency of lipoic acid synthase have an increased sensitivity to lipopolysaccharide-induced tissue injury. J Leukoc Biol (2008) 0.84
Blood utilization in patients with burn injury and association with clinical outcomes (CME). Transfusion (2012) 0.83
Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med (2002) 0.83
Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol (2014) 0.80
The White platelet syndrome: a new autosomal dominant platelet disorder. Platelets (2004) 0.79
Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network. Blood Coagul Fibrinolysis (2015) 0.79
Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia. Eur J Haematol (2012) 0.79
Role of the geneticist in testing and counseling for inherited thrombophilia. Genet Med (2003) 0.79
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor. Thromb Res (2012) 0.79
De novo synthesis of a narrow size distribution low-molecular-weight heparin. Glycobiology (2014) 0.78
Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients. Kidney Int (2011) 0.78
A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach. Thromb Res (2012) 0.78
Medical management of venous thromboembolism: what the interventional radiologist needs to know. Semin Intervent Radiol (2012) 0.78
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonance. PLoS One (2013) 0.78
Recombinant FVIIa for intractable hemorrhage: more questions than answers. Transfusion (2003) 0.78
Microparticles in thrombosis and hemostasis. Semin Thromb Hemost (2010) 0.77
Characteristics of abdominal vein thrombosis in children and adults. Thromb Haemost (2013) 0.77
Complications associated with carrier status among people with blood disorders: a commentary. Am J Prev Med (2010) 0.77
Prospective, multicenter study of postoperative deep-vein thrombosis in patients with haemophilia undergoing major orthopaedic surgery. Thromb Haemost (2016) 0.76
Stored platelets contain residual amounts of tissue factor: evidence from studies on platelet concentrates stored for prolonged periods. Transfusion (2005) 0.76
Congenital bleeding disorders. Hematology Am Soc Hematol Educ Program (2003) 0.76
Blood outgrowth endothelial cells as a vehicle for transgene expression of hepatocyte-secreted proteins via Sleeping Beauty. Endothelium (2007) 0.76
A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs? Br J Haematol (2014) 0.75
Effect of black tea intake on blood cholesterol concentrations in individuals with mild hypercholesterolemia: a diet-controlled randomized trial. J Acad Nutr Diet (2014) 0.75
The microbubble or the microparticle? J Appl Physiol (1985) (2010) 0.75
Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin Transplant (2007) 0.75
Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome. Thromb Haemost (2002) 0.75
Venous thromboembolism: From bench to bedside. Thromb Res (2009) 0.75
A 'touch' of the White platelet syndrome. Platelets (2005) 0.75
African-Americans have a higher rate of proximal deep vein thrombosis at presentation. Thromb Res (2010) 0.75
Responsiveness to desmopressin in von Willebrand disease. Curr Hematol Rep (2005) 0.75
Antifibrinolytic Therapy and Perioperative Considerations. Anesthesiology (2017) 0.75
Is homozygosity for the HR2 haplotype a risk factor for venous thromboembolism? Thromb Haemost (2002) 0.75